DIllian Whyte’s dream of a WBC title shot may have just gone up in smoke. News broke last night that “The Body Snatcher” failed a drug test ahead of his recent victory over Oscar Rivas, and the details that have emerged since paint an unpleasant picture.
Promoter Eddie Hearn’s statement neither confirms nor denies the report, but merely claims that “[b]oth fighters were cleared to fight.”
Further to reports I can confirm that both Dillian Whyte and Oscar Rivas were subject to extensive VADA and UKAD testing for their bout. Both fighters were cleared to fight by both bodies and the BBBofC— Eddie Hearn (@EddieHearn) July 24, 2019
The British Boxing Board of Control was similarly noncommittal.
The British Boxing Board of Control have released the following statement in response to reports saying Dillian Whyte failed a drugs test before his fight with Oscar Rivas. pic.twitter.com/3c128Tc8IV— Boxing on BT Sport (@BTSportBoxing) July 25, 2019
The failed test reportedly came three days ahead of last Saturdays’ bout.
When told about the initial positive, Whyte asked for his B sample to be tested, as is his right, which would not have been possible until this week. This meant Ukad, the sport’s governing body the British Boxing Board of Control, and the World Boxing Council’s chosen testing body the Voluntary Anti-Doping Agency had little option but to allow him to fight.
The key, damning detail: Rivas (26-1, 18 KO) and his team were not informed of the failed test.
It is with great stupefaction we have learned yesterday, on @boxingscene, the news about the testing result of @DillianWhyte, before the @WBCBoxing title against our @OscarKaboom. Up to this moment nobody on the concerned parties have confirmed or denied to us this information.— Yvon Michel (@yvonmichelGYM) July 25, 2019
Team Rivas had already filed a protest over what they alleged to be shady gloving practices before the fight even happened.
As far as the substance itself, veteran journalist Thomas Hauser reports that Whyte (26-1, 18 KO) tested positive for two metabolites of the anabolic steroid Dianabol. Whyte had previously served a two-year suspension for the stimulant methylhexaneamine in 2012.
I do want to stress that we have not received official confirmation or denial from Whyte, his team, UK Anti-Doping, or the BBBofC. Neither have we gotten the results from Whyte’s B sample. Even if said sample winds up exonerating Whyte, however, the lack of transparency with Rivas’ team is inexcusable.
We’ll have more as this develops.